NVP-BEZ235-induced autophagy as a potential therapeutic approach for multiple myeloma.

Yongyong Ma(Wenzhou Medical University), Qifa Liu(University of Science and Technology of China), Zhouxiang Jin(Wenzhou Medical University), Kang Yu(Wenzhou Medical University)
PubMed
January 1, 2019
Cited by 24

Related Papers

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma
|Frontiers in Immunology|2017|209
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells
|Leukemia|2020|53
Prognostic Significance of Pretreatment Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Patients with Diffuse Large B-Cell Lymphoma
|BioMed Research International|2018|50
Phase 1 Trial of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells in Relapsed/Refractory Multiple Myeloma
|Blood|2019|40